Saving 175 Jumbo Jets Full of Men
The results were exciting — a study revealed that a medication lowered prostate cancer risks by nearly 25 percent. But researchers found that men taking the medication who did develop prostate cancer tended to have a more aggressive disease.
Bald is Beautiful, But Beware
Baldness affects about 60 percent of men at some time in their lives. Researchers now think baldness and prostate cancer may be linked in African American men.
Men Have Hormonal Blues Too
Most prostate cancers are fed by male hormones called androgens. So treating the disease often involves blocking these hormones. It’s called androgen deprivation therapy (ADT), and it’s been used for decades – but not without controversy.
Solving Prostate Cancer Diagnostic Dilemma
Men can have elevated PSA (prostate-specific antigen) levels, and later undergo a biopsy only to find out that they do not have prostate cancer. That's a problem with PSA tests - they don't distinguish between benign (non-cancerous) disease and prostate cancer.
With Testosterone, It's Love and Hate
Cancer patients have to filter through a lot of very unfamiliar terms that only vaguely seem to make any sense. It's a lot to process, during a very emotional time.
FDA Drug Safety Communication: 5-alpha reductase inhibitors (5-ARIs)
The U.S. Food and Drug Administration (FDA) is informing healthcare professionals that the Warnings and Precautions section of the labels for the 5-alpha reductase inhibitor (5-ARI) class of drugs has been revised to include new safety information about the increased risk of being diagnosed with a more serious form of prostate cancer (high-grade prostate cancer).